Kenneth Bamberger quoted by jWeekly.com, Dec. 15, 2016
As Bamberger notes, Cal’s scholarly approach to the study of Israel has mellowed the campus climate by “creating multiple ongoing opportunities for students and faculty to delve deeply into the range of aspects of Israeli society and engage intellectually. That’s what universities do well.”
Jen Moreno quoted by The Washington Post, Dec. 14, 2016
“Virginia’s secrecy law incentivizes the state to use compounded drugs, even when manufactured drugs are available, because the purchase from the compounding pharmacy is made confidential,” Jennifer Moreno of Berkeley Law School’s Lethal Injection Project said in a statement. “Use of compounded drugs gratuitously adds risks of pain and suffering, and buying drugs from a compounding pharmacy is significantly more expensive and thus a questionable use of taxpayer money.”
Peter Menell quoted by Ars Technica, Dec. 14, 2016
“In my view, Cisco is seeking to benefit from the Federal Circuit’s misinterpretation of 9th Circuit law regarding APIs,” Menell said in an e-mail exchange with Ars. “By including a patent claim, despite the relatively small magnitude of Cisco’s patent damage request, Cisco ensured that the Federal Circuit, rather than the 9th Circuit, would have appellate jurisdiction over the far more valuable copyright causes of action.”
Steven Davidoff Solomon writes for The New York Times, Dec. 13, 2016
To prevent Mr. Zuckerberg from further cementing his grip on Facebook, shareholders have sued in a Delaware court, seeking to block the stock plan. A similar legal effort was tried against Google’s new class of shares, but that lawsuit was settled on terms that I described as providing little benefit to shareholders. This time around, however, the plaintiffs’ lawyers may have hit pay dirt.
Steven Davidoff Solomon quoted by American Banker, Dec. 13, 2016
After the Business Roundtable decision, Berkeley law professor Steven Davidoff commented disapprovingly. He wrote, “The opinion appears to create an almost insurmountable barrier for the SEC by requiring that it provide empirical support amounting to proof that its rules would be effective.”
Holly Doremus quoted by The Sacramento Bee, Dec. 12, 2016
“It remains to be seen the extent to which (California law) gets swept by the wayside,” said Holly Doremus, an expert on water law at UC Berkeley. “I think it will lead to litigation over these kinds of issues.”
Megan McCracken quoted by Associated Press, Dec. 11, 2016
Virginia added midazolam to its drug protocol in 2014 but has not yet used it. Megan McCracken … said Virginia would be the first state she knows of to use compounded midazolam to execute an inmate.
David Gamage writes for The San Francisco Examiner, Dec. 11, 2016
It can be quite easy for administrators at California’s public universities to breach agreements without suffering consequences, because public employees often face significant obstacles in enforcing employment contracts, whether or not that seems fair.
Pamela Samuelson writes for The Chronicle of Higher Education, Dec. 11, 2016
If faculty members, in particular, get smarter about copyright and publishing contracts, universities may be able to make their research more widely available. … Such dissemination serves universities’ teaching and research missions, and the interests of scholars who write to have an impact on their students, their fields of study, and the larger society.
Holly Doremus quoted by Los Angeles Times, Dec. 9, 2016
Supporters may say it doesn’t change the Endangered Species Act, but “I think that’s probably not exactly true when they’re this prescriptive. It probably is going to override” the act’s rules, said Holly Doremus. … Doremus said other parts of the new policy were contradictory and could spawn a barrage of lawsuits. “It is awfully messy. There will be a lot of litigation,” she predicted.